Skip to main content
. 2014 May 22;2014(5):CD002947. doi: 10.1002/14651858.CD002947.pub2

Comparison 38. Ayurvedic SGCG versus celecoxib.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain VAS 0‐100 change from baseline 1 220 Mean Difference (IV, Random, 95% CI) ‐2.0 [‐7.42, 3.42]
2 WOMAC 0‐4 (Function) change from baseline 1 220 Mean Difference (IV, Random, 95% CI) 0.19 [‐2.59, 2.97]
3 Participants (n) reported adverse events 1 208 Odds Ratio (M‐H, Random, 95% CI) 0.82 [0.45, 1.48]